GSTP1 and cancer: The loss of GSTP1, primarily through epigenetic silencing, has been reported in various cancers (Cui et al, 2020; Rønneberg et al, 2008; Su et al, 2007), and could make proximal tubule cells in the kidney, which metabolise these compounds, more vulnerable to genotoxic stress (Young et al, 2018).